... Ltd, Approval Carboplatin I.V. Injection, Akorn Inc, Approval Levetiracetam Tablets, Methapharm, Inc, Approval Losartan Potassium Tablets, Actavis, Inc, Tentative Approval Orapred ODT (prednisolone sodium phosphate) Orally Disintegrating Tablets, Shionogi Pharma, Inc, Labeling Revision Ranitidine Hydrochloride Syrup, Aurobindo Pharma, Approval Riluzole Tablets, Glenmark Generics Ltd, Tentative Approval Rocuronium Bromide Injection, Sagent Strides LLC, Approval Simcor (niacin and simvastatin) Tablets, Abbott Laboratories, Manufacturing Revision Sumatriptan Succinate Subcutaneous Injection, Sagent Strides LLC, Approval Twynsta (telmisartan and amlodipine besylate) Tablets, Boehringer Ingelheim Pharmaceuticals, Inc, Labeling Revision July 28, 2010 Aricept (donepezil hydrochloride) Tablets, Eisai Inc, Approval Cyclobenzaprine Hydrochloride Tablets, Invagen Pharmaceuticals, Inc, Approval Enoxaparin Sodium Subcutaneous Injection, Sandoz Inc, Approval Heparin Sodium Injection, Sagent Pharmaceuticals, Inc, Approval Methylphenidate Hydrochloride Oral Solution, Tris Pharma, Inc, Approval Relistor (methylnaltrexone bromide) Subcutaneous Solution, Progenics Pharmaceuticals, Inc, Labeling Revision Relpax (eletriptan hydrobromide) Tablets, Pfizer Inc, Labeling Revision Tribenzor (olmesartan medoxomil ...